How to Choose Your First
Aesthetic Device

01

Why this decision is harder than it looks

Most practitioners approach their first device purchase the way they approach clinical decisions — research the technology, evaluate the evidence, make the call. That instinct is correct, but incomplete. Aesthetic devices are not just clinical tools. They are the centerpiece of a revenue model.

Three things make this decision genuinely difficult:

• The market is crowded and confusing. There are dozens of device categories and hundreds of individual machines, many with overlapping indications and very similar marketing language. Vendors have strong financial incentives to position their device as the most versatile, most effective, and best value — regardless of whether that is true for your specific practice.
• The numbers are rarely what they seem. A vendor might quote you a $30,000 monthly revenue potential. That number is real — for a fully utilized device in the right market with the right patient base. Utilization rate, package pricing, and patient demand are variables that depend heavily on your specific situation.
• The opportunity cost is invisible. Every dollar spent on Device A is a dollar not spent on Device B. If you choose body contouring when your patient base is primarily interested in skin rejuvenation, you have not just bought a slow device — you have delayed the revenue you could have been generating.

02

Understanding realistic device costs

Before you evaluate a single device, it helps to understand what quality actually costs in this market. The price range is wide, the marketing is loud, and the first number a vendor quotes is rarely the number that tells the whole story. Getting grounded in realistic expectations before your first demo call means you evaluate devices on outcomes and fit — not on sticker shock in either direction.

What does a first device actually cost?

The aesthetic device market spans a wide range. Legacy brands and multi-platform systems from major manufacturers can run $80,000 to $150,000 or more. Purpose-built single-modality devices with equivalent or superior clinical outcomes typically sit between $35,000 and $60,000. The price difference rarely reflects a difference in clinical results — it reflects brand overhead, distributor margins, and decades of legacy pricing. Going into significant debt to carry a well-known name is one of the most common first-buyer mistakes. Patients do not ask which brand treated them. They ask whether the results are real.

Beyond the purchase price, build these into your budget:

• Consumables and disposables. Some devices — particularly microneedling systems — have per-treatment consumable costs that meaningfully affect your per-treatment margin. Ask for the cost per treatment upfront.
• Training. Good manufacturers include clinical training, but factor in the time cost of your staff. A proper training protocol takes one to two days minimum.
• Marketing. Some manufacturers — including Estetique — provide partners with a complete bimonthly marketing content package, social media assets, and patient education materials as part of the partnership. Others provide nothing. Ask specifically what marketing support comes with the device before you budget for it separately.
• Financing costs. If you are financing the purchase, the interest cost over the term is a real expense that affects your payback period.

What about machines under $10,000?

Every practitioner evaluating their first device asks this question at some point: why not just buy the $5,000 machine? It looks similar, treats similar areas, and the price difference is enormous.

The short answer: those devices do not work — and they carry real regulatory and reputational risk. The overwhelming majority of aesthetic devices priced under $10,000 are manufactured overseas, in markets with no equivalent to the FDA's regulatory framework. They are not FDA-cleared.

• FDA clearance requires manufacturers to demonstrate safety and efficacy for the device's intended use, with supporting clinical data. A device without it has not passed that bar — you have no evidence it does what it claims.
• Non-FDA-cleared devices cannot be legally marketed for medical or aesthetic treatments in the United States. Using one in a clinical setting exposes your practice to liability.
• The technology is typically underpowered. RF devices, for example, require specific energy levels and treatment protocols to produce real results. Budget devices frequently cannot reach or sustain the parameters needed for effective treatment.
• Patient outcomes suffer. Patients who spend money on treatments that produce no visible results do not come back — and they tell others.

Practitioners who buy budget devices almost universally report the same outcome: low patient satisfaction, refund requests, and eventually replacing the device with a quality system — having spent the budget twice. The $5,000 machine is not a saving. It is a detour.

Financing vs. cash purchase

Most practices finance their first device rather than paying cash — and for good reason. A device generating $25,000 per month with a $1,500 monthly payment is an excellent trade. Flexible financing options, including deferred payment structures and low monthly payments, make it possible to get a high-quality device revenue-generating before it is fully paid off.

03

The technology landscape in plain English

There are five major categories of energy-based aesthetic devices. Understanding what each one does — and what it does not do — is the foundation of a good purchase decision.

RF body contouring

Radiofrequency energy heats tissue to stimulate collagen production and disrupt fat cells. Used for body contouring, circumference reduction, skin tightening, and cellulite treatment. Results are progressive — typically visible after four to eight sessions — making it well-suited to package-based selling. Strong commercial track record, broad demographic appeal, and high repeat patient potential. The GLP-1 wave has significantly increased demand for body contouring among patients experiencing rapid weight loss.

CO2 laser resurfacing

Ablative CO2 lasers remove the outer layers of skin, triggering a wound-healing response that produces new collagen and dramatically improved skin texture. The gold standard for wrinkles, scarring, and sun damage. Higher price point per treatment, longer patient downtime (seven to fourteen days), and strong demand among patients willing to invest in significant results.

RF microneedling

Combines mechanical microneedling with radiofrequency energy delivered through insulated needles. Effective for skin tightening, pore refinement, acne scarring, and stretch marks. Less downtime than ablative laser, suitable for a broader range of skin tones, and popular with younger demographics. Package-friendly and strong social media content potential.

Laser hair removal

The most volume-driven category in aesthetic medicine — predictable, high-frequency, and built on a natural package model of six to eight sessions per area. Technology choice matters: diode lasers are the current standard for most skin tones, alexandrite offers faster treatment times for lighter skin, and Nd:YAG is the safest option for darker skin. IPL is technically not a laser and is less effective in most head-to-head comparisons.

LED phototherapy

Low-level light therapy using specific wavelengths to stimulate cellular activity. Non-ablative, no downtime, effective as a standalone or adjunct treatment. Lower price point and revenue ceiling per treatment, but excellent as an add-on that increases session value without significant additional chair time.

04

Matching technology to your patient mix

The right device for your practice is the intersection of three things: what your current patients want, what your target patients want, and what you can credibly deliver and market.

Start with your existing patient base

Pull the last twelve months of appointment data and look for patterns. What treatments are patients already asking about? What referrals are you turning away? What are patients in your demographic seeking from competitors? This is more reliable than any market research report.

The demographics that drive each category

• Body contouring: Ages 30–60, post-pregnancy, post-weight loss, individuals who exercise but struggle with targeted fat. Strong demand in Latin American and multicultural markets. GLP-1 patients represent a significant and growing cohort.
• CO2 resurfacing: Ages 30–65. While 40–65 drives most demand — sun damage, deep wrinkles, acne scarring — younger patients in their 30s are increasingly using lower-intensity CO2 settings for skin refreshing with minimal downtime and results that measurably outperform microneedling. It is a wider demographic than most practitioners expect. Higher income bracket across all ages.
• RF microneedling: Ages 28–55, skin-quality-focused, moderate downtime tolerance. Strong crossover appeal and social media content potential.
• Laser hair removal: Ages 18–45, broad demographic appeal, high volume potential. Particularly strong with younger patient bases and in markets with high aesthetic awareness.

Creating demand vs. following it

Conventional wisdom says to buy what your patients are already asking for. That is sound — but incomplete. Some of the most successful device investments are made ahead of demand, not in response to it. Being the first practice in your market to offer a specific treatment is a real competitive advantage. Patients who discover a treatment through your practice become your patients, not your competitor's.

The question is not whether patients are currently asking for it, but whether the demand exists in your demographic and whether you have the marketing support to build awareness. With the right content, education, and promotion behind a new category, you can create demand that did not exist before. The practices that lead their markets rarely do so by following what patients are already requesting.

05

Vendor due diligence — what to ask, what to watch for

Every vendor will tell you their device is the best. Your job is to get past the sales narrative and evaluate the actual company, support model, and clinical track record.

Questions to ask before any demo

• How many units of this specific device are in the field, and for how long? A device with 5,000+ units deployed over several years has a real track record.
• Can you connect me with three current customers in practices similar to mine? A confident manufacturer makes this easy. Reluctance is a signal.
• What does clinical training consist of, and who delivers it? In-person, hands-on training with a clinical specialist is the standard.
• What is your technical support model? Hours of availability, response time, and whether they have biomedical engineers — not just call center staff — matter.
• What is the consumable cost per treatment for this device?
• What does the warranty cover and for how long?
• What marketing support do you provide post-sale — content, patient education materials, co-branded campaigns?

Red flags to watch for

• Vague answers about support. "We have a great team" is not an answer. Ask for specifics: hours, response times, who handles field service.
• No clinical evidence beyond marketing materials. Ask for real patient before-and-after results and documented clinical outcomes — not just brochures and renderings.
• A manufacturer who cannot name competitors or dismisses all alternatives without substantive comparison.

The demo

Most reputable manufacturers today offer comprehensive virtual demonstrations — and the best of them are genuinely informative. A good virtual demo walks you through live treatment footage, real patient results, and the full device workflow in detail. What to evaluate: are the before-and-after results real and documented? Does the team answer your specific questions or run a scripted presentation? Do they know your market and patient demographic?

06

How to model ROI before you commit

Vendor revenue projections are almost always best-case scenarios. Build your own model using conservative assumptions.

The inputs you need

• Equipment cost — total, including financing costs if applicable
• Package price you plan to charge patients
• Number of treatments per package
• Number of packages you can realistically sell per month — start conservative, four to eight for a new device without existing demand
• Consumable cost per treatment, if applicable
• Estimated staff time per treatment

The utilization reality check

A device that can treat eight patients per day is not going to run at that capacity in month one. A realistic ramp: two to four patients per week in months one and two, growing to eight to twelve per week by months four to six as your marketing builds and word of mouth develops. Model your payback period on months three to six utilization, not peak capacity.

07

The most common first-buyer mistakes

Waiting for demand before investing in a category

Some of the most successful device investments are made ahead of demand, not in response to it. Being the first practice in your market to offer a specific treatment is a real competitive advantage. With the right marketing behind a new category, you can create demand that did not exist before. The practices that lead their markets rarely do so by following what patients are already requesting.

Underestimating the marketing requirement

A new device does not sell itself. Every successful device launch involves active patient education — before-and-after content, social media, email campaigns, and in-office consultations. Practices that assume patients will discover a new treatment organically consistently underperform those that actively promote it.

That said, this burden varies significantly by manufacturer. Estetique provides partners with a complete bimonthly marketing content package — social media assets, patient education materials, and ready-to-use campaign content — as part of the partnership. When evaluating any device, ask specifically what marketing support the manufacturer provides post-sale. It is one of the most underrated differences between suppliers.

Buying the cheapest option in the category

In aesthetic devices, the low-cost option typically involves lower power output, fewer treatment applicators, limited clinical support, or a manufacturer without the scale to maintain reliable service. The revenue ceiling on a budget device is real — and so is the patient satisfaction ceiling.

Next steps

A practical sequence to follow

Choosing your first aesthetic device is a significant decision, but a learnable one. The practices that get it right share a few characteristics: they start with patient demand or market opportunity rather than name brand prestige, they model ROI conservatively before committing, and they choose manufacturers based on outcomes and support — not on who has the biggest marketing budget or the most recognizable name.

• Map your patient base against the technology categories in Section 3 to identify the highest-demand — or highest-opportunity — category for your market.
• Be realistic about what quality costs. Meaningful clinical results come from properly engineered, FDA-cleared devices — not the cheapest option in the category, and not the most recognized brand name. The sweet spot exists and it delivers.
• Request introductions to current customers from every vendor you are seriously considering.
• Model your ROI using the framework in Section 6 and the Estetique calculator at estetique.com/roi.
• Book a virtual demo — evaluate whether the team answers your questions or runs a script.